Renewable sites › GlaxoSmithKline Wind Project
GlaxoSmithKline Wind Project
GlaxoSmithKline Wind Project is an operational 7.5 MW onshore wind farm in North Ayrshire, generating since 30 June 2013. Planning permission was granted on 1 May 2012, 28 months after submission. Operator of record: Glaxosmithkline.
Planning and build timeline
| Application submitted | 6 January 2010 |
| Permission granted | 1 May 2012 28 months after submission |
| Operational | 30 June 2013 14 months after consent |
Screening a site of your own?
North Ayrshire approves 78% of onshore wind schemes. Redline puts that number, and everything else the record holds, against your own boundary: the authority’s actual approval rate and decision times, every designation inside the red line, agricultural grade, 1 m LIDAR earthworks, how contested the grid is, and yield with a P90 — before you spend on a consultant.
Arrives prefilled with GlaxoSmithKline Wind Project’s recorded coordinate — swap in your own postcode or coordinates.
North Ayrshire’s record on onshore wind
North Ayrshire has decided 18 onshore wind schemes and approved 78%, taking a median of 8.5 months. See every onshore wind scheme decision in North Ayrshire →
Other built sites within 15 km
| Site | MW | Distance |
|---|---|---|
Wind Onshore · Under Construction | 3 | 0.3 km |
Solar Photovoltaics · Under Construction | 19.9 | 0.4 km |
Anaerobic Digestion · Operational | 1 | 0.4 km |
EfW Incineration · Under Construction | 17 | 0.6 km |
Solar Photovoltaics · Under Construction | 5 | 1 km |
Wind Onshore · Operational | 2.5 | 1.1 km |
Biomass (dedicated) · Operational | 26 | 2.1 km |
Solar Photovoltaics · Under Construction | 7.5 | 3.1 km |
How big is GlaxoSmithKline Wind Project?
GlaxoSmithKline Wind Project has a recorded installed capacity of 7.5 MW. That figure is the capacity registered in REPD, which is the scheme as consented — the metered output of a site can differ.
Who operates GlaxoSmithKline Wind Project?
REPD records the operator as Glaxosmithkline. Ownership of built renewable assets changes hands regularly and REPD is published quarterly, so treat this as the operator of record rather than confirmation of who owns it today.
When was GlaxoSmithKline Wind Project approved and built?
The application was submitted on 6 January 2010. Permission was granted on 1 May 2012, 28 months later. The site became operational on 30 June 2013, 14 months after consent.
Source: Renewable Energy Planning Database (REPD), Department for Energy Security and Net Zero, Open Government Licence v3.0, plus planning designation boundaries from planning.data.gov.uk (England only). REPD is published quarterly and covers schemes of roughly 150 kW and above. Capacity is the installed capacity on record, not metered generation. Operator is the operator of record at the last extract, not confirmation of present ownership. Reference 3841.
Novarly Parcel · official public data, read properly · parcel.novarly.com
All sites · Screen your own site · Planning by council · Coal mining search by postcode